Palivizumab injection used to prevent severe RSV infection in high-risk infants
Contains palivizumab 50 mg, a monoclonal antibody that helps prevent severe respiratory syncytial virus (RSV) infection in premature infants and children at high risk of lung disease.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse by intramuscular injection, once monthly during RSV season.
• Dose is calculated by the doctor based on body weight.
• Tell your doctor about any allergies before the injection.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Synagis 50mg/0.5ml 1 Vial (Refregirated) has been copied